157 related articles for article (PubMed ID: 37894450)
1. A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer.
Lyu XD; Liu Y; Wang J; Wei YC; Han Y; Li X; Zhang Q; Liu ZR; Li ZZ; Jiang JW; Hu HL; Yuan ST; Sun L
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894450
[TBL] [Abstract][Full Text] [Related]
2. C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinoma.
Yang M; Su Y; Wang Z; Du D; Wei S; Liao Z; Zhang Q; Zhao L; Zhang X; Han L; Jiang J; Zhan M; Sun L; Yuan S; Zhou Z
Biochem Pharmacol; 2021 Aug; 190():114641. PubMed ID: 34077738
[TBL] [Abstract][Full Text] [Related]
3. C118P exerted potent anti-tumor effects against melanoma with induction of G2/M arrest via inhibiting the expression of BUB1B.
Ren K; Zhou M; Li L; Wang C; Yuan S; Li H
J Dermatol Sci; 2022 Nov; 108(2):58-67. PubMed ID: 36424293
[TBL] [Abstract][Full Text] [Related]
4. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
[TBL] [Abstract][Full Text] [Related]
5. Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells.
Wang W; Pan H; Ren F; Chen H; Ren P
Biosci Rep; 2022 Mar; 42(3):. PubMed ID: 35237783
[TBL] [Abstract][Full Text] [Related]
6. Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2.
Zhou P; Liang X; Zhou C; Qin J; Hou C; Zhu Z; Zhang W; Wang S; Zhong D
J Mater Chem B; 2019 Sep; 7(35):5363-5375. PubMed ID: 31403158
[TBL] [Abstract][Full Text] [Related]
7. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
Wang L; Liu Y; Zhao TL; Li ZZ; He JY; Zhang BJ; Du HZ; Jiang JW; Yuan ST; Sun L
Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314
[TBL] [Abstract][Full Text] [Related]
8. Topotecan induces hepatocellular injury via ASCT2 mediated oxidative stress.
Zhou G; Qin M; Zhang X; Yang J; Yu H
Gastroenterol Hepatol; 2021 Jan; 44(1):1-12. PubMed ID: 33039171
[TBL] [Abstract][Full Text] [Related]
9. Lobetyolin inhibits the proliferation of breast cancer cells
Chen Y; Tian Y; Jin G; Cui Z; Guo W; Zhang X; Liu X
Hum Exp Toxicol; 2021 Dec; 40(12):2074-2086. PubMed ID: 34075790
[TBL] [Abstract][Full Text] [Related]
10. An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models.
Osanai-Sasakawa A; Hosomi K; Sumitomo Y; Takizawa T; Tomura-Suruki S; Imaizumi M; Kasai N; Poh TW; Yamano K; Yong WP; Kono K; Nakamura S; Ishii T; Nakai R
Am J Cancer Res; 2018; 8(8):1499-1513. PubMed ID: 30210919
[TBL] [Abstract][Full Text] [Related]
11. The pro-proliferative effect of interferon-γ in breast cancer cell lines is dependent on stimulation of ASCT2-mediated glutamine cellular uptake.
Silva C; Andrade N; Rodrigues I; Ferreira AC; Soares ML; Martel F
Life Sci; 2021 Dec; 286():120054. PubMed ID: 34662550
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide promotes apoptosis and oxidative injury of porcine small intestinal epithelial cells by down-regulating the expression of glutamine transporter ASCT2.
Tang X; Xiong K; Liu J; Li M
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37410896
[TBL] [Abstract][Full Text] [Related]
13. miR-122-5p Restrains Pancreatic Cancer Cell Growth and Causes Apoptosis by Negatively Regulating ASCT2.
Ren P; Wu NA; Fu S; Wang W; Li QI; Cheng Q
Anticancer Res; 2023 Oct; 43(10):4379-4388. PubMed ID: 37772564
[TBL] [Abstract][Full Text] [Related]
14. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
Wang Q; Hardie RA; Hoy AJ; van Geldermalsen M; Gao D; Fazli L; Sadowski MC; Balaban S; Schreuder M; Nagarajah R; Wong JJ; Metierre C; Pinello N; Otte NJ; Lehman ML; Gleave M; Nelson CC; Bailey CG; Ritchie W; Rasko JE; Holst J
J Pathol; 2015 Jul; 236(3):278-89. PubMed ID: 25693838
[TBL] [Abstract][Full Text] [Related]
15. High-affinity glutamate transporter GLAST/EAAT1 regulates cell surface expression of glutamine/neutral amino acid transporter ASCT2 in human fetal astrocytes.
Gegelashvili M; Rodriguez-Kern A; Pirozhkova I; Zhang J; Sung L; Gegelashvili G
Neurochem Int; 2006; 48(6-7):611-5. PubMed ID: 16516348
[TBL] [Abstract][Full Text] [Related]
16. The role of the glutamine transporter ASCT2 in antineoplastic therapy.
Teixeira E; Silva C; Martel F
Cancer Chemother Pharmacol; 2021 Apr; 87(4):447-464. PubMed ID: 33464409
[TBL] [Abstract][Full Text] [Related]
17. Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth.
Ye J; Huang Q; Xu J; Huang J; Wang J; Zhong W; Chen W; Lin X; Lin X
J Cancer Res Clin Oncol; 2018 May; 144(5):821-833. PubMed ID: 29435734
[TBL] [Abstract][Full Text] [Related]
18. lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2.
Wen Q; Huang M; Xie J; Liu R; Miao Q; Huang J; Zhang J; Lyu W; Qi M; Wu C; Qi Q; Zhang Z; Deng R; Wang C; Chen ZS; Zhang D; Ye W; Chen M
Drug Resist Updat; 2023 Jul; 69():100975. PubMed ID: 37207473
[TBL] [Abstract][Full Text] [Related]
19. ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells.
Luo Y; Li W; Ling Z; Hu Q; Fan Z; Cheng B; Tao X
Cancer Med; 2020 May; 9(10):3489-3499. PubMed ID: 32162845
[TBL] [Abstract][Full Text] [Related]
20. Sorting nexin 27 (SNX27) regulates the trafficking and activity of the glutamine transporter ASCT2.
Yang Z; Follett J; Kerr MC; Clairfeuille T; Chandra M; Collins BM; Teasdale RD
J Biol Chem; 2018 May; 293(18):6802-6811. PubMed ID: 29563155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
